2025
- Akdemir D, Auletta JJ, Bupp C, Maiers M, Bolon YT Establishment of a machine learning-based prediction framework to assess trade-offs in decisions that affect post-HCT outcomes. Comput Biol Med 2025 Apr 15 191 110113
- Bhatt NS, Lehmann L, Dandoy CE, Auletta JJ, Badia P, Ballard SA, Blacken R, Daraiseh NM, Desmond C, Dunseath C, Epling P, Fitch TJ, Flesch L, Hartley D, Huber J, Jenssen K, Kent G, Klunk A, Kapadia M, Kusnier K, Liberio N, Maier S, Myers KC, O'Connor G, Tarquini S, Phelan R, Pai A, Rotz S Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation Part I: Integrative Analysis of Mental Health, Psychosocial Stressors, and Support Mechanisms. Transplant Cell Ther 2025 Apr 21
- Hakim H, Richardson T, Riggs R, Auletta JJ, DiGerolamo K, Hron JD, Kohorst M, Laurie K, Maixner M, Mulcahy Levy JM, Ohlsen TJD, Orsey AD, Prudowsky ZD, Raghu VK, Redfern W, Rozenfeld RA, Workman JK, Wilkes JJ, IPSO COLLABORATIVE INVESTIGATORS Sepsis Mortality in Hospitalized Children With Cancer Is Associated With Lack of a Screening Tool. Hosp Pediatr 2025 Feb 12
- Phelan R, Rotz S, Dandoy CE, Auletta JJ, Badia P, Bhatt NS, Ballard SA, Blacken R, Daraiseh NM, Desmond C, Dunseath C, Epling P, Flesch L, Huber J, Jenssen K, Kapadia M, Kent G, Klunk A, Kusnier K, Lehmann L, Liberio N, Maier S, Myers KC, O'Connor G, Pai A, Tarquini S, Fitch TJ, Hartley D Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to Mitigation. Transplant Cell Ther 2025 May 10
- Preussler JM, DeSalvo AM, Tweeten B, Klaphake J, Cody MR, McGhee PM, Dawson KS, Schoeppner K, Auletta JJ Proceedings from the Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell Transplant. Transplant Cell Ther 2025 Apr 12
- Ramos KN, Auletta JJ Receiving CAR T-cells gets faster, but not for all in need. Blood Adv 2025 Jan 28 9 436-438
- Rutman L, Richardson T, Auletta J, Balamuth F, Chambers A, Fitzgerald J, Gelvez J, Genzel KA, Grant A, Gunnala V, Hakim H, Hueschen L, Kandi S, Larsen G, Lockwood J, Lucey K, Mack E, Madden K, Niedner M, Paul R, Reddy A, Riggs R, Rosen J, Schafer M, Scott H, Wilkes J, Eisenberg MA, Improving Pediatric Sepsis Outcomes Collaborative Investigators Association between Child Opportunity Index and paediatric sepsis recognition and treatment in a large quality improvement collaborative: a retrospective cohort study. BMJ Qual Saf 2025 May 8
- Silbert SK, Rankin AW, Hoang CN, Semchenkova A, Myers RM, Zerkalenkova E PhD, Wang HW, Kovach AE, Yuan CM, Delgado Colon D, Vasseur L, Bataller A, John S, Utley Lyons K, Friedes BD, Alonso-Saladrigues A, Abdel-Azim H, Balducci E, Aljudi A, Balsat M, Biery DN, Chamdin A, Chang BH, Cuevo RS MD, De Moerloose B, Dickens DS, Duffner UA, Duployez N, El Chaer F, Elliott MA, Escherich G, Fernandes S, Fitzjohn MR, Gahvari ZJ, Grupp SA, He RR MD, Harrison C, Hergott CB, Hsieh EM, Kim AS, Kuo DJ, Larson DP, Lee BJ, Leguay TT, Lindsley RC, Mangaonkar AA, Mezger K, Pacenta HL, Pan J, Provost MRM, Puri L, Raikar SS, Martinez AJ, Bristol IQ, Murphy KD, Reiman L, Redell MS, Reed K, Roth Guepin G, Rubinstein JD, Savasan S, Schafernak KT, McLean Stevens A, Talleur AC, Torres Carapia N, Vargaftig J, Vatsayan A, Wölfl M, Zhao L, Rives S, Fabrizio VA, Sasaki K, Aldoss I, Boissel N, Rheingold SR, Davis KL, Ghorashian S, Jacoby E, Popov A, Lamble AJ, Shah NN Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia. Blood 2025 Apr 7
2024
- Al-Huniti A, Marshall L, Rusk D, Pruthi RK, Rodriguez V, Ferdjallah A, Kuhn A Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders. Haemophilia 2024 Mar 20
- Albisetti M, Ardila J, Astermark J, Blatny J, Carcao M, Chowdary P, Connell NT, Crato M, Dargaud Y, d'Oiron R, Dunn AL, Escobar MA, Ettingshausen CE, Fischer K, Gouider E, Harroche A, Hermans C, Jimenez-Yuste V, Kaczmarek R, Kenet G, Khoo L, Klamroth R, Langer F, Lillicrap D, Mahlangu J, Male C, Mancuso ME, Matsushita T, Meunier S, Miesbach W, Nolan B, Oldenburg J, O'Mahony B, Ozelo M, Pierce GF, Ramos G, Recht M, Romero-Lux O, Rotellini D, Santoro RC, Singleton TC, Skinner MW, Srivastava A, Susen S, Talks K, Tran H, Valentino LA, Windyga J, Yang R, also on behalf of AICE, AHAD-AP, AHCDC, ATHN, CLAHT, EHC, French CRH & MHEMO, GTH, HTCCNC, NBDF, PEDNET, UKHCDO, WFH International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal. Haemophilia 2024 Dec 6
- Andres S, Huang K, Shatara M, Abdelbaki MS, Ranalli M, Finlay J, Gupta A Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies. Pediatr Blood Cancer 2024 Mar 30 e30979
- Ashruf OS, Ashruf Z, Orozco Z, Zinter M, Abu-Arja R, Yerigeri K, Haq IU, Kaelber DC, Bissler J, Raina R Epidemiology, Risk Factors, and Clinical Outcomes of AKI in Pediatric Hematopoietic Stem Cell Transplant Patients. Kidney360 2024 Jun 1 5 802-811
- Auletta JJ Health inequity has no boundaries. Lancet Haematol 2024 Dec 11 e883-e884
- Auletta JJ, Holter-Chakrabarty J, Munshi P, Wall S, Khera N, Knutson J, Gomez-Arteaga A, Hall AG, Foster J, Ruffin A, Robb D, Nemecek E, Rouce R, Davies SM, ACCESS Workshop Team Members Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplant Cell Ther 2024 Sep 12
- Bajaj N, Reed SM, Myers RE, Mahan JD, Ponitz K Exploration of What Pediatric Residents Find Most Helpful from Their Programs in Facilitating Well-Being. Acad Pediatr 2024 Nov 26 102607
- Ballen K, Wang T, He N, Knight JM, Hong S, Frangoul H, Verdonck LF, Steinberg A, Diaz MA, LeMaistre CF, Badawy SM, Pu JJ, Hashem H, Savani B, Sharma A, Lazarus HM, Abid MB, Tay J, Rangarajan HG, Kindwall-Keller T, Freytes CO, Beitinjaneh A, Winestone LE, Gergis U, Farhadfar N, Bhatt NS, Schears RM, Gómez-Almaguer D, Aljurf M, Agrawal V, Kuwatsuka Y, Seo S, Marks DI, Lehmann L, Wood WA, Hashmi S, Saber W Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation. Transplant Cell Ther 2024 Jul 20
- Bayanjargal A, Taslim C, Showpnil IA, Selich-Anderson J, Crow JC, Lessnick SL, Theisen ER The DBD-a4 helix of EWS::FLI is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma. bioRxiv 2024 Jan 31
- Beaupin L, Borinstein S, Yeager ND, Rokitka D, Schweitzer J, Uwazurike O, Senall J, Amankwah E, Shaw PH Piloting a Patient-Driven Online Survey to Better Understand Cancer in Adolescents and Young Adults (AYA) in the United States. Cureus 2024 Jul 16 e63749
- Benhayoun A, Olsavsky A, Akard TF, Gerhardt C, Skeens MA Predictors of loneliness among middle childhood and adolescence during the COVID-19 pandemic. PLoS One 2024 19 e0308091
- Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H, Elfeky R, Lewalle P, Laberko A, Ghosh S, Slatter MA, Weemaes CMR, Yesilipek A, Sirait T, Neven B, Gennery AR, Lankester AC, Inborn Errors Working Party (IEWP) of the European Society for Immunodeficiencies (ESID), the European Society for Blood and Marrow Transplantation (EBMT) and the European Reference Network that aims at improving the care of patients with rare immunological disorders (ERN-RITA) Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study. J Clin Immunol 2024 Aug 21 44 182
- Bhatt NS, Meyer CL, Mau LW, Auletta JJ, Baker KS, Broglie L, Carpenter PA, Choi SW, Dandoy CE, Devine S, Phelan R Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States. Bone Marrow Transplant 2024 Feb 20
- Bhattacharyya S, Oblinger JL, Beauchamp RL, Kosa L, Robert F, Plotkin SR, Chang LS, Ramesh V Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models. Neurooncol Adv 2024 Jan-Dec 6 vdae024
- Bhayana S, Dougherty JA, Kamigaki Y, Agrawal S, Wijeratne S, Fitch J, Waller AP, Wolfgang KJ, White P, Kerlin BA, Smoyer WE Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation. iScience 2024 Jan 19 27 108631
- Bolon YT, Atshan R, Allbee-Johnson M, Estrada-Merly N, Auletta JJ, Broglie L, Cusatis R, Page KM, Phelan R, Sajulga R Jr, Shaw BE, Spahn A, Steinert P, Stewart V, Vierra-Green C, Lee SJ, Spellman SR Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes. Transplant Cell Ther 2024 Jun 11
- Canella A, Artomov M, Ukhatov A, Rajendran S, Perez P, Saini U, Hedberg J, Cassady K, Rajappa P Primary murine high-grade glioma cells derived from RCAS/tv-a diffuse glioma model reprogram naive T cells into immunosuppressive regulatory T lymphocytes. Mol Ther Oncol 2024 Sep 19 32 200861
- Chu Y, Nayyar G, Tian M, Lee DA, Ozkaynak MF, Ayala-Cuesta J, Klose K, Foley K, Mendelowitz AS, Luo W, Liao Y, Ayello J, Behbehani GK, Riddell S, Cripe T, Cairo MS Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts. Mol Ther Oncol 2024 Jun 20 32 200820
- Ciurea SO, Kongtim P, Srour S, Chen J, Soebbing D, Shpall E, Rezvani K, Nakkula R, Thakkar A, Troy EC, Cash AA, Behbehani G, Cao K, Schafer J, Champlin RE, Lee DA Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. Am J Hematol 2024 Mar 5
- Coleman JR, Gumina R, Hund T, Cohen M, Neal MD, Townsend K, Kerlin BA Sex dimorphisms in coagulation: Implications in trauma-induced coagulopathy and trauma resuscitation. Am J Hematol 2024 Apr 99 Suppl 1 S28-S35
- Colton ZA, Liles SM, Griffith MM, Stanek CJ, Walden J, King A, Barnard-Kirk T, Creary S, Nahata L Using the consolidated framework for implementation research to identify challenges and opportunities for implementing a reproductive health education program into sickle cell disease care. J Pediatr Psychol 2024 May 2
- Creary S, Chung MG, Villella AD, Lo WD Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future. Curr Neurol Neurosci Rep 2024 Sep 21
- Creary S, Kebodeaux C, Nahata L Hydroxyurea and follicle density in sickle cell. Blood Adv 2024 Oct 8 8 5225-5226
- Creary S, Liles SM, Colton ZA, Stanek CJ, Hudnall MC, Quinn GP, Nahata L Experiences and outcomes of fertility testing in male adolescents with sickle cell disease. Pediatr Blood Cancer 2024 Jan 10 e30848
- Creary S, Reeves S Assessing the Quality of Care for Children With Sickle Cell Anemia: We Are Still Failing. Pediatrics 2024 Apr 1 153
- Cripe TP Reviving the lost art of meeting reports. Mol Ther Oncol 2024 Mar 21 32 200781
- Cripe TP, Roberts RD, Chandler DS, Setty BA, Chen S, Shenoy A, Venkataramany AS, Ringwalt EM, Scharschmidt T, Utset-Ward T, Konieczkowski DJ, Grignol VP, Beane JD, Ruff SM, Pollock RE Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society. Mol Ther Oncol 2024 Mar 21 32 200779
- Cripe TP, Roberts RD, Chandler DS, Setty BA, Chen S, Shenoy A, Venkataramany AS, Ringwalt EM, Scharschmidt T, Utset-Ward T, Konieczkowski DJ, Grignol VP, Beane JD, Ruff SM, Pollock RE Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society. Mol Ther Oncol 2024 Mar 21 32 200779
- Cripe TP, Roberts RD, Chandler DS, Setty BA, Chen S, Shenoy A, Venkataramany AS, Ringwalt EM, Scharschmidt T, Utset-Ward T, Konieczkowski DJ, Grignol VP, Beane JD, Ruff SM, Pollock RE Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society. Mol Ther Oncol 2024 Mar 21 32 200779
- Cripe TP, Roberts RD, Chandler DS, Setty BA, Chen S, Shenoy A, Venkataramany AS, Ringwalt EM, Scharschmidt T, Utset-Ward T, Konieczkowski DJ, Grignol VP, Beane JD, Ruff SM, Pollock RE Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society. Mol Ther Oncol 2024 Mar 21 32 200779
- Cripe TP, Roberts RD, Chandler DS, Setty BA, Chen S, Shenoy A, Venkataramany AS, Ringwalt EM, Scharschmidt T, Utset-Ward T, Konieczkowski DJ, Grignol VP, Beane JD, Ruff SM, Pollock RE Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society. Mol Ther Oncol 2024 Mar 21 32 200779
- Cruz Vidal D, Lee S, Ardoin SP, Dalmacy D, Chaparro J, Blaney C, Rodriguez V, Sankar A, Akoghlanian S, Lisciandro R, Washam M, Abraham RS, Leber A, Eby M, Bennett B, Erdem G Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience. Pediatr Infect Dis J 2024 May 1 43 e160-e163
- Cruz Vidal D, Lee S, Ardoin SP, Dalmacy D, Chaparro J, Blaney C, Rodriguez V, Sankar A, Akoghlanian S, Lisciandro R, Washam M, Abraham RS, Leber A, Eby M, Bennett B, Erdem G Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience. Pediatr Infect Dis J 2024 May 1 43 e160-e163
- Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE Current trends and outcomes in cellular therapy activity in the United States, including prospective Patient Reported Outcomes data collection within the CIBMTR registry. Transplant Cell Ther 2024 Jun 27
- Dandoy CE, Auletta JJ, Badia P, Bidgoli A, Daraiseh NM, DeSalvo AM, Diaz J, Davies SM, Demmel K, Cook E, Craddock JA, Huber J, Sampson M, Fitch TJ, French K, Jodele S, Jaglowski SM, Kapadia MA, Khera N, Kent GR, Leung KS, Lehmann LE, Liang WH, Maier S, Nelson A, Nishitani M, O'Mathúna D, Johnson DJ, Magee K, Pai A, Parker LM, Phelan R, Epling P, Rotz S, Salem BM, Snyder A, Juckett M, Hartley D Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. Transplant Cell Ther 2024 Dec 30
- Davila J, O'Brien SH, Mitchell WB, Manwani D Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap. Br J Haematol 2024 Apr 5
- Delap S, Shah N, Kuns O, Franklin B, Skeens MA Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series. Pediatr Blood Cancer 2024 Apr 71 e30903
- DeSalvo AM, Spellman SR, Coles JAS, Robb D, McCann M, Yusuf RA, Hengen M, Auletta JJ Applying implementation science in the field of transplant and cellular therapy. Transplant Cell Ther 2024 Jun 21
- Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM Phase II Trial of Gemcitabine and nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation. Clin Cancer Res 2024 Oct 3
- Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement. J Natl Compr Canc Netw 2024 Dec 27 1-7
- Dillon LW, Gui G, Ravindra N, Andrew G, Mukherjee D, Wong ZC, Huang Y, Gerhold J, Holman M, D'Angelo J, Miller J, Higgins J, Salk JJ, Auletta JJ, El Chaer F, Devine SM, Jimenez-Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger SL, Page KM, Hourigan CS Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia. JAMA Oncol 2024 May 2
- Dreyzin A, Rankin AW, Luciani K, Gavrilova T, Shah NN Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy. Expert Rev Clin Immunol 2024 Jul 20 745-763
- Dunn A, Dargaud Y, Abajas Y, Carcao M, Castaman G, Giermasz A, Hermans C, Jiménez-Yuste V, Lewandowska M, Mahlangu J, Meeks S, Miesbach W, Recht M, Salinas V, Chrisentery-Singleton T, Bonzo D, Mitchell IS, Wilkinson TA, Young G Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors. Haemophilia 2024 Dec 15
- Fan T, Shah R, Wang R Metabolic footprint and logic through the T cell life cycle. Curr Opin Immunol 2024 Sep 21 91 102487
- Fang J, Singh S, Wells B, Wu Q, Jin H, Janke LJ, Wan S, Steele JA, Connelly JP, Murphy AJ, Wang R, Davidoff AM, Ashcroft M, Pruett-Miller SM, Yang J The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven cancer. Res Sq 2024 May 31
- Farhadfar N, Rashid N, Chen K, DeVos JD, Wang T, Ballen KK, Beitinjaneh A, Bhatt VR, Hamilton BK, Hematti P, Gadalla SM, Solomon SR, El Jurdi N, Lee CJ, MacMillan ML, Rangarajan HG, Schoemans HM, Sharma A, Spellman SR, Wingard JR, Lee SJ Racial, Ethnic and Socioeconomic Diversity and Outcomes of Patients with Graft-versus-Host Disease: A CIBMTR Analysis. Blood Adv 2024 May 22
- Fetzko S, Gupta AA, Setty BA, Malone MW, Schraw J, Lupo PJ, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatr Blood Cancer 2024 Dec 9 e31477
- Fingrut WB, Troyer J, Russell E, Aviles MM, Della-Moretta S, Dobson D, Hasanali ZS, Hu B, Lapite A, Pillai PM, Schramm J, Villagomez L, Vo P, Wang'ondu R, Yui JC, Weyand AC The American Society of Hematology Health Equity Compendium: examining health equity across the Blood Journals. Blood Adv 2024 Jul 5
- Gaylord WC, Trout AT, Audino AN, Belsky JA An International Survey Investigating the Incidence and Management of Brown Fat Uptake on (18)F-FDG PET/CT at Children's Hospitals and Interventions for Mitigation. J Nucl Med Technol 2024 Jun 5 52 115-120
- Gomez-Arteaga A, Chokr N, Auletta JJ Precision medicine results from equitable representation. Bone Marrow Transplant 2024 Oct 21
- Grom AA, Canna SW, Abu-Arja RF, Sinha R, Peixoto L, Cannizzaro E, Chandrakasan S, Driest K, Marsh R, Neven B, Onel K, Prahalad S, Prockop S, Quartier P, Roth J, Schulert G, Silva JMF, Wall D, Zeilhofer U Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe. Pediatr Rheumatol Online J 2024 Jan 5 21 86
- Gui G, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong Z, Auletta JJ, El Chaer F, Chen EC, Chen YB, Corner A, Devine SM, Iyer SG, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger SL, Page KM, Dillon LW, Hourigan CS Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplant 2024 Nov 6
- Gui G, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong Z, Auletta JJ, El Chaer F, Chen EC, Chen YB, Corner A, Devine SM, Iyer SG, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger SL, Page KM, Dillon LW, Hourigan CS Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplant 2024 Oct 25
- Hallam M, Pruett A, Biega C, Miller H, Davis T, Casto L, Dunn AL, Rodriguez V Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study. J Pediatr Hematol Oncol Nurs 2024 Aug 8 27527530241246260
- Hallam M, Pruett A, Biega C, Miller H, Davis T, Casto L, Dunn AL, Rodriguez V Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study. J Pediatr Hematol Oncol Nurs 2024 Aug 8 27527530241246260
- Hegde PS, Andrew G, Gui G, Ravindra N, Mukherjee D, Wong ZC, Auletta JJ, El Chaer F, Corner A, Devine SM, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger SL, Page KM, Dillon LW, Hourigan CS Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplant 2024 Oct 18
- Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101). medRxiv 2024 Jan 25
- Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study. Clin Infect Dis 2024 May 27
- Hu Y, Sarkar A, Song K, Michael S, Hook M, Wang R, Heczey A, Song X Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity. Cell Rep Med 2024 Apr 22 101530
- Jablonowski CM, Quarni W, Singh S, Tan H, Bostanthirige DH, Jin H, Fang J, Chang TC, Finkelstein D, Cho JH, Hu D, Pagala V, Sakurada SM, Pruett-Miller SM, Wang R, Murphy A, Freeman K, Peng J, Davidoff AM, Wu G, Yang J Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. Elife 2024 Mar 15 12
- John TD, Walters MC, Rangarajan HG, Rahim MQ, McKinney CM, Bollard CM, Abusin G, Eapen M, Kassim AA, DeBaun MR Incremental Eligibility Criteria for the BMT CTN 1507 Haploidentical Trial for Children with Sickle Cell Disease. Blood Adv 2024 Oct 7
- Kahn AR, Davis ES, Dai C, Caudill CV, Martinez I, Brackett J, Sharma A, Schwalm C, Kebede A, Dickens DS, Richman J, Colace S, POCC Consortium, Araya B, Bhatia S, Wolfson JA, Levine JM, Johnston EE COVID-19 Disease in Children With ALL Receiving Maintenance Therapy: Do Not Discount the Risk. JCO Oncol Pract 2024 Aug 19 OP2300631
- Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton BK, Schoemans H, Abraham AA, Agrawal V, Auletta JJ, Badawy SM, Beitinjaneh A, Bhatt NS, Broglie L, Diaz Perez MA, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hayashi RJ, Hematti P, Hildebrandt GC, Inamoto Y, Kamble RT, Koo J, Lazarus HM, Mayo SJ, Mehta PA, Myers KC, Nishihori T, Prestidge T, Rotz SJ, Savani BN, Schears RM, Sharma A, Stenger E, Ustun C, Williams KM, Vrooman LM, Satwani P, Phelan R Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study. Lancet Child Adolesc Health 2024 Aug 29
- Kassim AA, de la Fuente J, Nur E, Wilkerson K, Alahmari A, Seber A, Bonfim CMS, Simões BP, Alzahrani M, Eckrich MJ, Horn B, Hanna R, Dhedin N, Rangarajan HG, Gouveia RV, Almohareb F, Aljurf M, Essa M, Alahmari B, Gatwood KS, Connelly JA, Dovern E, Rodeghier M, DeBaun MR An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease. Blood 2024 Mar 17
- Kaur M, Horowitz MM, Mendizabal A, Chen M, Foley A, Auletta JJ, Devine S, D'Souza A Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants. Transplant Cell Ther 2024 Nov 1
- Kebede AM, Garfinkle EAR, Mathew MT, Varga E, Colace SI, Wheeler G, Kelly BJ, Schieffer KM, Miller KE, Mardis ER, Cottrell CE, Potter SL Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center. Front Oncol 2024 14 1498409
- Kendel NE, Stanek JR, Willen FK, Audino AN Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults. Pediatr Hematol Oncol 2024 Apr 8 1-10
- Kendel NE, Stanek JR, Willen FK, Audino AN Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults. Pediatr Hematol Oncol 2024 Apr 8 1-10
- Kent MR, Silvius K, Kucinski J, Calderon D, Kendall GC Functional Genomics of Novel Rhabdomyosarcoma Fusion-Oncogenes Using Zebrafish. Methods Mol Biol 2024 2707 23-41
- Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, Ballen K, Abid MB, Díaz MA, Al-Homsi AS, Hashem H, Hong S, Munker R, Schears R, Lazarus HM, Ciurea SO, Badawy SM, Savani BN, Wirk B, LeMaistre CF, Bhatt NS, Beitinjaneh A, Aljurf M, Sharma A, Cerny J, Knight JM, Kelkar AH, Yared JA, Kindwall-Keller T, Winestone LE, Steinberg A, Arnold SD, Seo S, Preussler JM, Hossain NM, Fingrut WB, Agrawal V, Hashmi S, Lehmann LE, Wood WA, Rangarajan HG, Saber W, Hahn T Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities. Blood Adv 2024 Apr 25
- Khurshid S, Venkataramany AS, Montes M, Kipp JF, Roberts RD, Wein N, Rigo F, Wang PY, Cripe TP, Chandler DS Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma. Mol Ther Oncol 2024 Dec 19 32 200908
- Khurshid S, Venkataramany AS, Montes M, Kipp JF, Roberts RD, Wein N, Rigo F, Wang PY, Cripe TP, Chandler DS Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma. Mol Ther Oncol 2024 Dec 19 32 200908
- Kim TO, Geris JM Dr, Flanagan JM, Grace RF, Lambert MP, O'Farrell C, Rose MJ, Shimano KA, Niss O, Neunert CE, Nakano TA, MacMath D, Dinu B, Kirk SE, Neufeld EJ, Despotovic JM, Scheurer ME, Grimes AB Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric Immune Thrombocytopenia. Blood Adv 2024 Aug 27
- Kim Y, Saini U, Kim D, Hernandez-Aguirre I, Hedberg J, Martin A, Mo X, Cripe TP, Markert J, Cassady KA, Dhital R Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy. Front Immunol 2024 15 1375413
- Kim Y, Saini U, Kim D, Hernandez-Aguirre I, Hedberg J, Martin A, Mo X, Cripe TP, Markert J, Cassady KA, Dhital R Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy. Front Immunol 2024 15 1375413
- Kim YY, Gryder BE, Sinniah R, Peach ML, Shern JF, Abdelmaksoud A, Pomella S, Woldemichael GM, Stanton BZ, Milewski D, Barchi JJ Jr, Schneekloth JS Jr, Chari R, Kowalczyk JT, Shenoy SR, Evans JR, Song YK, Wang C, Wen X, Chou HC, Gangalapudi V, Esposito D, Jones J, Procter L, O'Neill M, Jenkins LM, Tarasova NI, Wei JS, McMahon JB, O'Keefe BR, Hawley RG, Khan J KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma. Nat Commun 2024 Feb 24 15 1703
- Kucinski J, Tallan A, Taslim C, Wang M, Cannon MV, Silvius KM, Stanton BZ, Kendall GC Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo. bioRxiv 2024 Jul 16
- Kucinski JP, Calderon D, Kendall GC Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas. Dis Model Mech 2024 Jun 1 17
- Lee U, Szabova L, Collins VJ, Gordon M, Johnson K, Householder D, Jorgensen S, Lu L, Bassel L, Elloumi F, Peer CJ, Nelson AE, Varriano S, Varma S, Roberts RD, Ohler ZW, Figg WD, Sharan SK, Pommier Y, Heske CM Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response. Front Cell Dev Biol 2024 12 1462840
- Lin JS, Coleman L, Voskuil RT, Malik A, Mayerson JL, Scharschmidt TJ Local recurrence rates of superficial versus deep soft tissue sarcoma. Arch Orthop Trauma Surg 2024 Jun 8
- Ljung R, Chan AKC, Ahuja SP, Mancuso ME, Marquez JFC, Volk F, Blanchette V, Kerlin BA, Trakymiene SS, Glosli H, Kenet G BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study. Eur J Haematol 2024 Dec 12
- Lundin B, Bakeer N, Dunn AL, Gibikote S, Keshava SN, Ljung RCR, Papakonstantinou O, Pergantou H, Strike K, Drygalski AV, Zhang N, Babyn P, Dover S, Doria AS International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0. Haemophilia 2024 Apr 18
- Luo W, Gardenswartz A, Hoang H, Chu Y, Tian M, Liao Y, Ayello J, Rosenblum JM, Mo X, Marcondes AM, Overwijk WW, Cripe TP, Lee DA, Cairo MS Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma. Mol Ther Oncol 2024 Dec 19 32 200894
- Luo W, Gardenswartz A, Hoang H, Chu Y, Tian M, Liao Y, Ayello J, Rosenblum JM, Mo X, Marcondes AM, Overwijk WW, Cripe TP, Lee DA, Cairo MS Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma. Mol Ther Oncol 2024 Dec 19 32 200894
- Luo W, Hoang H, Miller KE, Zhu H, Xu S, Mo X, Garfinkle EAR, Costello H, Wijeratne S, Chemnitz W, Gandhi R, Liao Y, Ayello J, Gardenswartz A, Rosenblum JM, Cassady KA, Mardis ER, Lee DA, Cripe TP, Cairo MS Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously. J Exp Clin Cancer Res 2024 Jul 11 43 193
- Luo W, Hoang H, Miller KE, Zhu H, Xu S, Mo X, Garfinkle EAR, Costello H, Wijeratne S, Chemnitz W, Gandhi R, Liao Y, Ayello J, Gardenswartz A, Rosenblum JM, Cassady KA, Mardis ER, Lee DA, Cripe TP, Cairo MS Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously. J Exp Clin Cancer Res 2024 Jul 11 43 193
- Luo W, Hoang H, Miller KE, Zhu H, Xu S, Mo X, Garfinkle EAR, Costello H, Wijeratne S, Chemnitz W, Gandhi R, Liao Y, Ayello J, Gardenswartz A, Rosenblum JM, Cassady KA, Mardis ER, Lee DA, Cripe TP, Cairo MS Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously. J Exp Clin Cancer Res 2024 Jul 11 43 193
- Luo W, Hoang H, Zhu H, Miller K, Mo X, Eguchi S, Tian M, Liao Y, Ayello J, Rosenblum JM, Marcondes M, Currier M, Mardis E, Cripe T, Lee D, Cairo MS Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy. J Immunother Cancer 2024 Sep 12 12
- Luo W, Hoang H, Zhu H, Miller K, Mo X, Eguchi S, Tian M, Liao Y, Ayello J, Rosenblum JM, Marcondes M, Currier M, Mardis E, Cripe T, Lee D, Cairo MS Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy. J Immunother Cancer 2024 Sep 12 12
- Macke EL, Miller AR, Stonerock E, Olshefski R, Zajo K, Bedrosian TA, Mardis ER, Akkari YMN, Cottrell CE, Schieffer KM A LINE-1 mediated deletion resulting in germline retinoblastoma predisposition. Neurooncol Adv 2024 Jan-Dec 6 vdad163
- Madan B, Ozelo MC, Raheja P, Symington E, Quon DV, Leavitt AD, Pipe SW, Lowe G, Kenet G, Reding MT, Mason J, Wang M, von Drygalski A, Klamroth R, Shapiro S, Chambost H, Dunn AL, Oldenburg J, Chou SC, Peyvandi F, Millar CM, Osmond D, Yu H, Dashiell-Aje E, Robinson TM, Mahlangu J Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A. J Thromb Haemost 2024 Apr 11
- Malec L, Peyvandi F, Chan AKC, Königs C, Zulfikar B, Yuan H, Simpson M, Álvarez Román MT, Carcao M, Staber JM, Dunn AL, Chou SC, d'Oiron R, Albisetti M, Demissie M, Santagostino E, Yarramaneni A, Wong N, Abad-Franch L, Gunawardena S, Fijnvandraat K, XTEND-Kids Trial Group Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A. N Engl J Med 2024 Jul 18 391 235-246
- Mason I, Hewitt GD, McCracken KA, Whiteside S, Nahata L, Kebodeaux CA Sexual and Reproductive Healthcare Following Gonadotoxic Treatment in Females at a Tertiary Pediatric Hospital. J Pediatr Adolesc Gynecol 2024 Jan 20
- Matt MG, Drozdov D, Bendstrup E, Glerup M, Hauge EM, Masmas T, Schneider EC, Zeilhofer UB, Abu-Arja RF, Driest KD, Oved JH, Onel K, Ebens CL, Chellapandian D, Chandrakasan S, Prahalad S, Roth J, Prockop SE, Silva J, Schapiro AH, Towe C, Chandra S, Grom A, Schulert GS, Marsh RA Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. Lancet Rheumatol 2024 Dec 20
- Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, Schonfeld SJ, Valcarcel B, Abrahão R, Yusuf RA, Muffly L Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study. Haematologica 2024 Aug 29
- Moertel CL, Hirbe AC, Shuhaiber HH, Bielamowicz K, Sidhu A, Viskochil D, Weber MD, Lokku A, Smith LM, Foreman NK, Hajjar FM, McNall-Knapp RY, Weintraub L, Antony R, Franson AT, Meade J, Schiff D, Walbert T, Ambady P, Bota DA, Campen CJ, Kaur G, Klesse LJ, Maraka S, Moots PL, Nevel K, Bornhorst M, Aguilar-Bonilla A, Chagnon S, Dalvi N, Gupta P, Khatib Z, Metrock LK, Nghiemphu PL, Roberts RD, Robison NJ, Sadighi Z, Stapleton S, Babovic-Vuksanovic D, Gershon TR, ReNeu Trial Investigators, ReNeu Study Investigators ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma. J Clin Oncol 2024 Nov 8 JCO2401034
- Moffatt ME, Ford R, Lujano BN, Reed S, Singh A, Stewart DA, Turner DA Competency based medical education - Where do I start? Curr Probl Pediatr Adolesc Health Care 2024 Aug 31 101674
- Montgomery KE, Alshakhshir N, Basha M, Geenen E, Nyholm L, Skeens MA An exploratory qualitative study on factors influencing the level of agreement in symptom reports in child-caregiver dyads. Palliat Support Care 2024 Oct 7 1-11
- Nakano TA, Grimes AB, Klaassen RJ, Lambert MP, Neunert CE, Rothman JA, Shimano KA, Amend C, Askew M, Badawy SM, Baker JM, Breakey V, Crary SE, Davini M, Fritch Lilla S, Gilbert M, Hays T, Hege K, Hillier K, Jacobson-Kelly A, Kaicker S, Kim TO, Kochhar M, Leblanc TM, Martinelli M, Nunez M, Remiker AS, Schultz CL, Sharma R, Grace RF What's in a name: defining pediatric refractory ITP. Blood Adv 2024 Jul 26
- Nikiforow S, Whangbo JS, Reshef R, Tsai DE, Bunin NJ, Abu-Arja RF, Mahadeo KM, Weng WK, Van Besien K, Loeb D, Nasta SD, Nemecek ER, Zhao W, Sun Y, Galderisi FC, Wahlstrom J, Mehta A, Gamelin LI Dr, Dinavahi R, Prockop SE Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Adv 2024 Apr 16
- O'Brien SH, Stanek JR, House A, Cronin RM, Creary SE, Roe AH, Vesely SK Trends in Pregnancy Outcomes in People with Sickle Cell Disease and Medicaid Insurance (2006-2018). J Womens Health (Larchmt) 2024 Oct 31
- O'Brien SH, Stanek JR, House A, Cronin RM, Creary SE, Roe AH, Vesely SK Trends in Pregnancy Outcomes in People with Sickle Cell Disease and Medicaid Insurance (2006-2018). J Womens Health (Larchmt) 2024 Oct 31
- Oblinger JL, Wang J, Wetherell GD, Agarwal G, Wilson TA, Benson NR, Fenger JM, Fuchs JR, Kinghorn AD, Chang LS Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas. Sci Rep 2024 Aug 20 14 19349
- Oladipupo F, Stanek J, Walden J, Young J, Rose MJ, Nicol K, Villella A, Creary S Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States. Pediatr Blood Cancer 2024 Mar 10 e30945
- Oladipupo F, Stanek J, Walden J, Young J, Rose MJ, Nicol K, Villella A, Creary S Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States. Pediatr Blood Cancer 2024 Mar 10 e30945
- Olsavsky AL, Ralph J, Benhayoun A, Hill KN, Guttoo P, Akard TF, Gerhardt C, Skeens MA COVID-19 impact, resilience, and child quality of life: A dyadic analysis. J Fam Psychol 2024 Mar 21
- Olsavsky AL, Sutherland-Foggio M, Stanek CJ, Hill KN, Himelhoch AC, Kenney AE, Humphrey L, Olshefski R, Skeens MA, Nahata L, Gerhardt CA Factors associated with caregiver strain among mothers and fathers of children with advanced cancer. Palliat Support Care 2024 Oct 4 1-9
- Paudel SN, Hutzen BJ, Miller KE, Garfinkle EAR, Chen CY, Wang PY, Glaspell AM, Currier MA, Ringwalt EM, Boon L, Mardis ER, Cairo MS, Ratner N, Dodd RD, Cassady KA, Cripe TP Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors. Front Immunol 2024 15 1384623
- Paudel SN, Hutzen BJ, Miller KE, Garfinkle EAR, Chen CY, Wang PY, Glaspell AM, Currier MA, Ringwalt EM, Boon L, Mardis ER, Cairo MS, Ratner N, Dodd RD, Cassady KA, Cripe TP Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors. Front Immunol 2024 15 1384623
- Pidala JA, Kim J, Kalos D, Cutler CS, DeFilipp Z, Flowers ME, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko CL, Ponce DM, Sung AD, Tang H, Farhadfar N, Nemecek ER, Pusic I, Qayed M, Rangarajan HG, Hogan WJ, Etra AM, Jaglowski SM Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis. Blood Adv 2024 Oct 25
- Ragoonanan D, Abdel-Azim H, Sharma A, Bhar S, McArthur J, Madden R, Rahrig A, Bajwa R, Wang J, Sun V, Wright M, Lassiter R, Shoberu B, Kawedia J, Khazal SJ, Mahadeo KM, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study. Lancet Reg Health Am 2024 May 33 100728
- Raina R, Doshi K, Aggarwal P, Kim P, Sasse J, Sethi S, Abitbol C, Abu-Arja R, Kashani K Application of artificial intelligence and machine learning for risk stratification acute kidney injury among hematopoietic stem cell transplantation patients: PCRRT ICONIC AI Initiative Group Meeting Proceedings. Clin Nephrol 2024 Nov 15
- Rankin AW, Duncan BB, Allen C, Silbert SK, Shah NN Evolving strategies for addressing CAR T-cell toxicities. Cancer Metastasis Rev 2024 Dec 15 44 17
- Rankin AW, Shah NN CD19 CAR T cells for multiple sclerosis: Forging further into the new frontier. Med 2024 Jun 14 5 482-484
- Rask GC, Taslim C, Bayanjargal A, Cannon MV, Selich-Anderson J, Crow JC, Duncan A, Theisen ER Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins. bioRxiv 2024 May 21
- Reinecke JB, Gross AC, Cam M, Garcia LJ, Cannon MV, Dries R, Gryder BE, Roberts RD Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells. bioRxiv 2024 Jan 12
- Reinecke JB, Jimenez Garcia L, Gross AC, Cam M, Cannon MV, Gust MJ, Sheridan JP, Gryder BE, Dries R, Roberts RD Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells. Clin Cancer Res 2024 Nov 14
- Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma. bioRxiv 2024 Mar 3
- Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma. bioRxiv 2024 Mar 3
- Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma. bioRxiv 2024 Mar 3
- Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma. Mol Ther Oncol 2024 Dec 19 32 200886
- Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma. Mol Ther Oncol 2024 Dec 19 32 200886
- Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma. Mol Ther Oncol 2024 Dec 19 32 200886
- Rodriguez V, Mitchell BS, Stanek J, Vasko K, Giver J, Monda K, Canini J, Dunn AA, Kumar R Improving Anticoagulation Care for Pediatric Oncology Patients: A Quality Improvement Initiative. Pediatr Qual Saf 2024 Jan-Feb 9 e720
- Rodriguez V, Mitchell BS, Stanek J, Vasko K, Giver J, Monda K, Canini J, Dunn AA, Kumar R Improving Anticoagulation Care for Pediatric Oncology Patients: A Quality Improvement Initiative. Pediatr Qual Saf 2024 Jan-Feb 9 e720
- Rodriguez V, Mitchell BS, Stanek J, Vasko K, Giver J, Monda K, Canini J, Dunn AA, Kumar R Improving Anticoagulation Care for Pediatric Oncology Patients: A Quality Improvement Initiative. Pediatr Qual Saf 2024 Jan-Feb 9 e720
- Rotz SJ, Hamilton BK, Wei W, Ahmed I, Winston SA, Ballard S, Bernard RJ, Carpenter P, Farhadfar N, Ferraro C, Friend BD, Gloude NJ, Hayashi RJ, Hoyle K, Jenssen K, Koo J, Lee CJ, Mariano L, Nawabit R, Ngwube A, Lalefar N, Phelan R, Perkins L, Rao A, Rayes A, Sandheinrich T, Stafford L, Tomlinson K, Whiteside S, Wiedl C, Myers K Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 2024 Feb 9
- Sahai I, Borgman P, Yates B, Rosenzweig S, Rampertaap S, Rankin AW, Shah NN Incidence of preexisting B-cell aplasia in B-ALL: implications for post-CAR T-cell monitoring. Blood Adv 2024 Dec 24 8 6329-6333
- Schaefer MR, Wojtowicz A, Gardner M, Patel P, Sutherland-Foggio M, Kenney AE, Himelhoch AC, Humphrey L, Olshefski R, Skeens MA, Gerhardt C "If We Don't Beat It, How Long Will It Take?" Worries and Concerns of Children with Advanced Cancer and Their Parents. J Palliat Med 2024 Nov 28
- Schaefer MR, Wojtowicz A, Gardner M, Patel P, Sutherland-Foggio M, Kenney AE, Himelhoch AC, Humphrey L, Olshefski R, Skeens MA, Gerhardt C "If We Don't Beat It, How Long Will It Take?" Worries and Concerns of Children with Advanced Cancer and Their Parents. J Palliat Med 2024 Nov 28
- Schaefer MR, Wojtowicz A, Gardner M, Patel P, Sutherland-Foggio M, Kenney AE, Himelhoch AC, Humphrey L, Olshefski R, Skeens MA, Gerhardt C "If We Don't Beat It, How Long Will It Take?" Worries and Concerns of Children with Advanced Cancer and Their Parents. J Palliat Med 2024 Nov 28
- Schaefer MR, Wojtowicz A, Gardner M, Patel P, Sutherland-Foggio M, Kenney AE, Himelhoch AC, Humphrey L, Olshefski R, Skeens MA, Gerhardt C "If We Don't Beat It, How Long Will It Take?" Worries and Concerns of Children with Advanced Cancer and Their Parents. J Palliat Med 2024 Nov 28
- Schafer ES, Rushing T, Crews KR, Annesley C, Colace SI, Kaiser N, Pommert L, Ramsey LB, Sabnis HS, Wong K, Chang BH, Cooper TM, Shah NN, Rheingold SR, Place AE, Chi YY, Bhojwani D, Wayne AS, Bernhardt MB Optimizing early phase clinical trial washout periods: a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. J Natl Cancer Inst 2024 Jul 4
- Schonfeld SJ, Valcarcel B, Meyer CL, Shaw BE, Phelan R, Rizzo JD, Brunson A, Cooley JJP, Abrahão R, Wun T, Gadalla SM, Engels E, Albert PS, Yusuf R, Spellman SR, Curtis RE, Auletta JJ, Muffly L, Keegan THM, Morton LM Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry. Blood Adv 2024 Aug 13 8 4102-4112
- Sezgin E, Kocaballi AB, Dolce M, Skeens M, Militello L, Huang Y, Stevens J, Kemper AR Chatbot for Social Need Screening and Resource Sharing With Vulnerable Families: Iterative Design and Evaluation Study. JMIR Hum Factors 2024 Jul 19 11 e57114
- Shaffer BC, Gooptu M, DeFor T, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez AM, Al Malki MM Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation. J Clin Oncol 2024 Nov 6 JCO2402108
- Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bolaños-Meade J, Abboud R, Briggs AD, Khimani F, Modi D, Newcomb R, Shpall EJ, Bupp C, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez Jimenez AM, Al Malki MM Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. J Clin Oncol 2024 Jul 17 JCO2400184
- Shenkar R, Kahwash SB, Rodriguez DP, Abu Arja R, Reed SM, Rangarajan HG Isolated Optic Nerve Relapse in a Pediatric Patient With T-Cell Lymphoblastic Leukemia: A Brief Report. J Pediatr Hematol Oncol 2024 Jun 4
- Shenkar R, Kahwash SB, Rodriguez DP, Abu Arja R, Reed SM, Rangarajan HG Isolated Optic Nerve Relapse in a Pediatric Patient With T-Cell Lymphoblastic Leukemia: A Brief Report. J Pediatr Hematol Oncol 2024 Jun 4
- Shenkar R, Kahwash SB, Rodriguez DP, Abu Arja R, Reed SM, Rangarajan HG Isolated Optic Nerve Relapse in a Pediatric Patient With T-Cell Lymphoblastic Leukemia: A Brief Report. J Pediatr Hematol Oncol 2024 Jun 4
- Siefring E, Olsavsky AL, Schaefer M, Sutherland-Foggio M, Himelhoch AC, Hill KN, Kenney AE, Humphrey L, Olshefski R, Gerhardt CA Benefit-finding in children with advanced cancer and their parents. Palliat Support Care 2024 Nov 15 1-7
- Singh S, Fang J, Jin H, Van de Velde LA, Wu Q, Cortes A, Morton CL, Woolard MA, Quarni W, Steele JA, Connelly JP, He L, Thorne R, Turner G, Confer T, Johnson M, Caufield WV, Freeman BB, Lockey T, Pruett-Miller SM, Wang R, Davidoff AM, Thomas PG, Yang J RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity. bioRxiv 2024 Mar 25
- Skeens MA, Jackson DI, Sutherland-Foggio MS, Sezgin E mHealth Apps in the Digital Marketplace for Pediatric Patients With Cancer: Systematic Search and Analysis. JMIR Pediatr Parent 2024 Oct 1 7 e58101
- Skeens MA, Kochashvili M, Benhayoun A, Ralph J, Bajwa R, Vannatta K, Gerhardt CA, Sezgin E Enhancing medication adherence: A family-centered co-designed mHealth app for children undergoing hematopoietic stem cell transplant. J Pediatr Nurs 2024 Oct 17
- Skeens MA, Montgomery KE Bridging Theory, Research, and Practice to Guide the Next Generation of Symptom Interventions. Cancer Nurs 2024 Jan-Feb 01 47 1-2
- Skinner MW, Albisetti M, Ardila J, Astermark J, Blatny J, Carcao M, Chowdary P, Connell NT, Crato M, Dargaud Y, d'Oiron R, Dunn AL, Escobar MA, Escuriola-Ettingshausen C, Gouider E, Harroche A, Hermans C, Jimenez-Yuste V, Kaczmarek R, Kenet G, Khoo L, Klamroth R, Langer F, Lillicrap D, Mahlangu J, Male C, Matsushita T, Meunier S, Miesbach W, Nolan B, Oldenburg J, O'Mahony B, Ozelo M, Pierce GF, Ramos G, Recht M, Romero-Lux O, Rotellini D, Santoro RC, Singleton TC, Srivastava A, Susen S, Talks K, Tran H, Valentino LA, Windyga J, Yang R, Mancuso ME, also on behalf of AICEAHAD-APAHCDCATHNCLAHTEHCFrench CRH & MHEMOHTCCNCNBDFPEDNETUKHCDOWFH Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease. Haemophilia 2024 Dec 9
- Stanton BZ, Pomella S Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges. Front Cell Dev Biol 2024 12 1416946
- Stute P, Akpan IJ, Breymann C, Murji A, O'Brien SH, Powers JM, Munro MG Effect of Ferric Derisomaltose on Fatigue in Iron Deficiency Anemia Associated With Abnormal Uterine Bleeding. Am J Hematol 2024 Dec 12
- Sutherland-Foggio M, Olsavsky AL, Skeens MA, Nahata L, Hill K, Schaefer M, Himelhoch A, Kenney AE, Humphrey L, Olshefski R, Gerhardt CA Mixed-method examination of factors associated with adolescent decision-making and involvement in care in the context of advanced cancer. Palliat Support Care 2024 Feb 14 1-8
- Sutherland-Foggio M, Olsavsky AL, Skeens MA, Nahata L, Hill K, Schaefer M, Himelhoch A, Kenney AE, Humphrey L, Olshefski R, Gerhardt CA Mixed-method examination of factors associated with adolescent decision-making and involvement in care in the context of advanced cancer. Palliat Support Care 2024 Feb 14 1-8
- Tallan A, Kucinski J, Sunkel B, Taslim C, LaHaye S, Liu Q, Qi J, Wang M, Kendall GC, Stanton BZ Highly quantitative measurement of differential protein-genome binding with PerCell chromatin sequencing. bioRxiv 2024 Jul 16
- Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers (Basel) 2024 May 30 16
- Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers (Basel) 2024 May 30 16
- Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers (Basel) 2024 May 30 16
- Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers (Basel) 2024 May 30 16
- Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers (Basel) 2024 May 30 16
- Walden J, Brown L, Seiguer S, Munshaw K, Rausch J, Badawy S, McGann P, Winkler S, Gonzalez L, Creary S Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease. PLoS One 2024 19 e0304644
- Walden J, Stanek JR, Ebersole AM, Nahata L, Creary SE Sexually transmitted infection testing and diagnosis in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer 2024 Oct 71 e31240
- Walden J, Stanek JR, Young J, Griffith MM, Nahata L, Creary SE Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic. Vaccine 2024 Aug 9 42 126212
- Waller AP, Muralidharan K, Kerlin BA PARticularly Forceful: PAR1 Drives Glomerular Mesangial Cell Contractility. Function (Oxf) 2024 Sep 18
- Waller AP, Wolfgang KJ, Pruner I, Stevenson ZS, Abdelghani E, Muralidharan K, Wilkie TK, Blissett AR, Calomeni EP, Vetter TA, Brodsky SV, Smoyer WE, Nieman MT, Kerlin BA Prothrombin Knockdown Protects Podocytes and Reduces Proteinuria in Glomerular Disease. bioRxiv 2024 Mar 2
- Wang H, Huang Y, Wang R Tonic-ing emissions and compatibility to turbocharge CAR-T. Nat Metab 2024 Apr 24
- Wang T, Liu L, Fang J, Jin H, Natarajan S, Sheppard H, Lu M, Turner G, Confer T, Johnson M, Steinberg J, Ha L, Yadak N, Jain R, Picketts DJ, Ma X, Murphy A, Davidoff AM, Glazer ES, Easton J, Chen X, Wang R, Yang J Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or Somatostatinoma. Cancer Res 2024 Nov 12
- Wang T, Liu L, Fang J, Jin H, Natarajan S, Sheppard H, Lu M, Turner G, Confer T, Johnson M, Steinberg J, Ha L, Yadak N, Jain R, Picketts DJ, Ma X, Murphy A, Davidoff AM, Glazer ES, Easton J, Chen X, Wang R, Yang J Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinoma. bioRxiv 2024 Mar 14
- Wright-Nadkarni ML, Nahata L, Audino AN Medical Trainee Education and Advocacy Regarding Sexual Health and Oncofertility: Gaps and Opportunities. J Adolesc Young Adult Oncol 2024 Jan 30
- Zinter MS, Dvorak CC, Mayday MY, Reyes G, Simon MR, Pearce EM, Kim H, Shaw PJ, Rowan CM, Auletta JJ, Martin PL, Godder K, Duncan CN, Lalefar NR, Kreml EM, Hume JR, Abdel-Azim H, Hurley C, Cuvelier GDE, Keating AK, Qayed M, Killinger JS, Fitzgerald JC, Hanna R, Mahadeo KM, Quigg TC, Satwani P, Castillo P, Gertz SJ, Moore TB, Hanisch B, Abdel-Mageed A, Phelan R, Davis DB, Hudspeth MP, Yanik GA, Pulsipher MA, Sulaiman I, Segal LN, Versluys BA, Lindemans CA, Boelens JJ, DeRisi JL, Pediatric Transplantation and Cell Therapy Consortium Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation. Nat Med 2024 May 23
Show More